Skip to content

Study · Randomized controlled trial · 2016

3 results

Influence of oxytocin on emotion recognition from body language: A randomized placebo-controlled trial.

Bernaerts S, Berra E, Wenderoth N, Alaerts K

Psychoneuroendocrinology5 Jul 2016Cited by 19 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanRandomized controlled trialEfficacy outcome

    In healthy adult males, a single dose of intranasal oxytocin had a significant effect of medium size on emotion recognition from body language versus placebo.

    In plain wordsIn healthy men, one dose of nasal oxytocin improved recognition of emotions from body movement compared with placebo.

    Peptide
    Oxytocin
    Outcome
    IncreaseEmotion recognition from body language
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    24 IU · intranasal · single doseAs given in this study (human).

    Source sentences

    Summary
    Overall, a single-dose of OT administration had a significant effect of medium size on emotion recognition from body language.
    1 context sentence
    Summary · context
    To do so, a double-blind between-subjects randomized placebo-controlled trial was conducted, assessing performance on a bodily emotion recognition task in healthy adult males before and after a single-dose of intranasal OT (24 IU).
  2. 02HumanRandomized controlled trialEfficacy outcome

    In healthy adult males, oxytocin-induced improvements in emotion recognition were not differentially modulated by positive versus negative valence.

    In plain wordsIn healthy men, oxytocin's effect on emotion recognition did not differ between positive and negative emotions.

    Peptide
    Oxytocin
    Outcome
    No significant changeModulation of oxytocin effect by emotional valence
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    24 IU · intranasal · single doseAs given in this study (human).

    Source sentences

    Summary
    OT-induced improvements in emotion recognition were not differentially modulated by the emotional valence of the presented stimuli (positive versus negative)
    1 context sentence
    Summary · context
    To do so, a double-blind between-subjects randomized placebo-controlled trial was conducted, assessing performance on a bodily emotion recognition task in healthy adult males before and after a single-dose of intranasal OT (24 IU).
  3. 03HumanRandomized controlled trialEfficacy outcome

    In healthy adult males, oxytocin did not change the overall tendency to label an observed emotional state as happy or angry.

    In plain wordsIn healthy men, oxytocin did not change how often they labelled an emotion as happy or angry, compared with placebo.

    Peptide
    Oxytocin
    Outcome
    No significant changeTendency to label emotional state as happy or angry
    Study

    n: not reported in source

    Comparator
    Placebo
    Outcome group
    Cognition and memory · Nervous system and cognition
    Studied dose
    24 IU · intranasal · single doseAs given in this study (human).

    Source sentences

    Summary
    also, the overall tendency to label an observed emotional state as 'happy' (positive) or 'angry' (negative) was not modified by the administration of OT.
    1 context sentence
    Summary · context
    To do so, a double-blind between-subjects randomized placebo-controlled trial was conducted, assessing performance on a bodily emotion recognition task in healthy adult males before and after a single-dose of intranasal OT (24 IU).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 01:30 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:50 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.